Search results
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 5 days agoIn March this year, the company reported positive interim immunogenicity data from the vaccine...
Long COVID Risk Factors Revealed In Data From Nearly 5,000 People
IFLScience· 2 days agoLong COVID describes a chronic condition that is present for at least three months after an...
FDA reverses course, calls for vaccines for fall 2024 to target newer COVID-19 strain
AOL· 5 days agoThe Food and Drug Administration provided updated guidance for COVID-19 vaccine makers, calling for...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
Medical Xpress· 7 days agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
SF wastewater levels show spike in COVID-19
The San Francisco Examiner· 2 days ago“In summer 2023, we saw wastewater concentrations for SARS-CoV-2 start to increase in mid-June and peak during August,” she told The ...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines
Reuters via Yahoo News· 6 days agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative vaccines ...
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Morningstar· 6 days ago"Today's vaccine efficacy data are consistent with the previously announced immunogenicity results from the study, which showed that mRNA-1283 had higher neutralizing antibody ...
COVID/Flu Experimental Vaccine Receives Positive R | Newswise
Newswise· 2 days agoThe trial for the dual-purpose vaccine involved more than four thousand adults ages 65 or older. The vaccine triggered immune responses to three flu variants ...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
The Virginian-Pilot· 7 days agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 4 days agoThe U.S. Food and Drug Administration (FDA) announced Thursday that manufacturers of the COVID vaccines should focus on the KP.2 strain of the JN.1 variant ...